Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

A quality improvement program to reduce the time on the lung transplant waiting list at the Nantes University Hospital.

Danner-Boucher I, Loppinet V, Boxus A, Dary C, Lambert AB, Prieur M, Vallet C, Tissot A.

Orphanet J Rare Dis. 2018 Feb 8;13(Suppl 1):11. doi: 10.1186/s13023-017-0748-4.

2.

Retrospective observational study of French patients with cystic fibrosis and a Gly551Asp-CFTR mutation after 1 and 2years of treatment with ivacaftor in a real-world setting.

Hubert D, Dehillotte C, Munck A, David V, Baek J, Mely L, Dominique S, Ramel S, Danner Boucher I, Lefeuvre S, Reynaud Q, Colomb-Jung V, Bakouboula P, Lemonnier L.

J Cyst Fibros. 2018 Jan;17(1):89-95. doi: 10.1016/j.jcf.2017.07.001. Epub 2017 Jul 12.

PMID:
28711222
3.

Prevalence of the reversed halo sign in neutropenic patients compared with non-neutropenic patients: Data from a single-centre study involving 27 patients with pulmonary mucormycosis (2003-2016).

Bourcier J, Heudes PM, Morio F, Gastinne T, Chevallier P, Rialland-Battisti F, Garandeau C, Danner-Boucher I, Le Pape P, Frampas E, Moreau P, Defrance C, Peterlin P.

Mycoses. 2017 Aug;60(8):526-533. doi: 10.1111/myc.12624. Epub 2017 Apr 21.

PMID:
28429890
4.

Chronic effects of air pollution on lung function after lung transplantation in the Systems prediction of Chronic Lung Allograft Dysfunction (SysCLAD) study.

Benmerad M, Slama R, Botturi K, Claustre J, Roux A, Sage E, Reynaud-Gaubert M, Gomez C, Kessler R, Brugière O, Mornex JF, Mussot S, Dahan M, Boussaud V, Danner-Boucher I, Dromer C, Knoop C, Auffray A, Lepeule J, Malherbe L, Meleux F, Nicod L, Magnan A, Pison C, Siroux V; SysCLAD consortium.

Eur Respir J. 2017 Jan 18;49(1). pii: 1600206. doi: 10.1183/13993003.00206-2016. Print 2017 Jan.

5.

Evaluation of quantitative PCR for early diagnosis of Pseudomonas aeruginosa infection in cystic fibrosis: a prospective cohort study.

Héry-Arnaud G, Nowak E, Caillon J, David V, Dirou A, Revert K, Munck MR, Frachon I, Haloun A, Horeau-Langlard D, Le Bihan J, Danner-Boucher I, Ramel S, Pelletier MP, Rosec S, Gouriou S, Poulhazan E, Payan C, Férec C, Rault G, Le Gal G, Le Berre R.

Clin Microbiol Infect. 2017 Mar;23(3):203-207. doi: 10.1016/j.cmi.2016.11.016. Epub 2016 Nov 27.

6.

Identifying the educational needs of lung transplant recipients with cystic fibrosis.

David V, Feldman D, Danner-Boucher I, Rhun AL, Guyomarch B, Ravilly S, Marchand C.

Prog Transplant. 2015 Mar;25(1):18-25. doi: 10.7182/pit2015526.

PMID:
25758796
7.

Systematic analysis of blood cell transcriptome in end-stage chronic respiratory diseases.

Chesné J, Danger R, Botturi K, Reynaud-Gaubert M, Mussot S, Stern M, Danner-Boucher I, Mornex JF, Pison C, Dromer C, Kessler R, Dahan M, Brugière O, Le Pavec J, Perros F, Humbert M, Gomez C, Brouard S, Magnan A; COLT Consortium.

PLoS One. 2014 Oct 20;9(10):e109291. doi: 10.1371/journal.pone.0109291. eCollection 2014.

8.

Impact of donor-to-recipient weight ratio on survival after bilateral lung transplantation.

Delom F, Danner-Boucher I, Dromer C, Thumerel M, Marthan R, Nourry-Lecaplain L, Magnan A, Jougon J, Fessart D.

Transplant Proc. 2014 Jun;46(5):1517-22. doi: 10.1016/j.transproceed.2014.02.015.

PMID:
24935323
9.

[Perceptions of cystic fibrosis patients, patient relatives and physicians: barriers or motivations to lung transplantation].

Marchand C, Salhi L, Le Rhun A, Ravilly S, Danner-Boucher I, Gagnayre R, David V.

Rev Mal Respir. 2014 Mar;31(3):237-47. doi: 10.1016/j.rmr.2013.06.004. Epub 2013 Sep 3. French.

PMID:
24680115
10.

Severe pulmonary hypertension leading to heart-lung transplantation and revealing breast cancer.

Madjer T, Danner-Boucher I, Horeau-Langlard D, Haloun A, Lepoivre T, Sagan C, Magnan A.

Eur Respir J. 2012 Oct;40(4):1057-9. No abstract available.

11.

CFTR biomarkers: time for promotion to surrogate end-point.

De Boeck K, Kent L, Davies J, Derichs N, Amaral M, Rowe SM, Middleton P, de Jonge H, Bronsveld I, Wilschanski M, Melotti P, Danner-Boucher I, Boerner S, Fajac I, Southern K, de Nooijer RA, Bot A, de Rijke Y, de Wachter E, Leal T, Vermeulen F, Hug MJ, Rault G, Nguyen-Khoa T, Barreto C, Proesmans M, Sermet-Gaudelus I; European Cystic Fibrosis Society Clinical Trial Network Standardisation Committee.

Eur Respir J. 2013 Jan;41(1):203-16. doi: 10.1183/09031936.00057512. Epub 2012 Aug 9. Review.

12.

High prevalence of triazole resistance in Aspergillus fumigatus, especially mediated by TR/L98H, in a French cohort of patients with cystic fibrosis.

Morio F, Aubin GG, Danner-Boucher I, Haloun A, Sacchetto E, Garcia-Hermoso D, Bretagne S, Miegeville M, Le Pape P.

J Antimicrob Chemother. 2012 Aug;67(8):1870-3. doi: 10.1093/jac/dks160. Epub 2012 May 11.

PMID:
22581906
13.

One-year experience with high-emergency lung transplantation in France.

Boussaud V, Mal H, Trinquart L, Thabut G, Danner-Boucher I, Dromer C, Raymond CS, Reynaud-Gaubert M, Kessler R, Philit F, Dorent R, Stern M.

Transplantation. 2012 May 27;93(10):1058-63. doi: 10.1097/TP.0b013e31824d7079.

PMID:
22531492
14.

Phaeohyphomycosis due to Alternaria infectoria: a single-center experience with utility of PCR for diagnosis and species identification.

Robert T, Talarmin JP, Leterrier M, Cassagnau E, Le Pape P, Danner-Boucher I, Malard O, Brocard A, Gay-Andrieu F, Miegeville M, Morio F.

Med Mycol. 2012 Aug;50(6):594-600. doi: 10.3109/13693786.2012.663508. Epub 2012 Mar 12.

PMID:
22404860
15.

Disseminated Scedosporium/Pseudallescheria infection after double-lung transplantation in patients with cystic fibrosis.

Morio F, Horeau-Langlard D, Gay-Andrieu F, Talarmin JP, Haloun A, Treilhaud M, Despins P, Jossic F, Nourry L, Danner-Boucher I, Pattier S, Bouchara JP, Le Pape P, Miegeville M.

J Clin Microbiol. 2010 May;48(5):1978-82. doi: 10.1128/JCM.01840-09. Epub 2010 Mar 10.

Supplemental Content

Loading ...
Support Center